ZORA_ECO24
ID ZORA_ECO24 Reviewed; 729 AA.
AC A7ZI10;
DT 03-AUG-2022, integrated into UniProtKB/Swiss-Prot.
DT 03-AUG-2022, sequence version 2.
DT 03-AUG-2022, entry version 56.
DE RecName: Full=Zorya protein ZorA {ECO:0000303|PubMed:29371424};
GN Name=zorA {ECO:0000303|PubMed:29371424};
GN OrderedLocusNames=EcE24377A_0285 {ECO:0000312|EMBL:ABV17222.1};
OS Escherichia coli O139:H28 (strain E24377A / ETEC).
OC Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC Enterobacteriaceae; Escherichia.
OX NCBI_TaxID=331111;
RN [1] {ECO:0000312|EMBL:ABV17222.1}
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=E24377A / ETEC;
RX PubMed=18676672; DOI=10.1128/jb.00619-08;
RA Rasko D.A., Rosovitz M.J., Myers G.S.A., Mongodin E.F., Fricke W.F.,
RA Gajer P., Crabtree J., Sebaihia M., Thomson N.R., Chaudhuri R.,
RA Henderson I.R., Sperandio V., Ravel J.;
RT "The pangenome structure of Escherichia coli: comparative genomic analysis
RT of E. coli commensal and pathogenic isolates.";
RL J. Bacteriol. 190:6881-6893(2008).
RN [2]
RP FUNCTION, SUBCELLULAR LOCATION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF
RP THR-147 AND SER-184.
RC STRAIN=E24377A / ETEC;
RX PubMed=29371424; DOI=10.1126/science.aar4120;
RA Doron S., Melamed S., Ofir G., Leavitt A., Lopatina A., Keren M.,
RA Amitai G., Sorek R.;
RT "Systematic discovery of antiphage defense systems in the microbial
RT pangenome.";
RL Science 359:0-0(2018).
CC -!- FUNCTION: Component of antiviral defense system Zorya type I, composed
CC of ZorA, ZorB, ZorC and ZorD. Expression of Zorya type I in E.coli
CC (strain MG1655) confers 10,000-fold resistance to phage SECphi27, 100-
CC fold resistance to lambda, and 10-fold resistance to T7. While most T7
CC infected Zorya-containing cells undergo abortive infection, a minority
CC produce viable phage progeny. These eventually accumulate to a high
CC multiplicity of infection, leading to culture collapse by 2 hours after
CC initial infection (PubMed:29371424). ZorA and ZorB probably assemble in
CC the cell inner membrane and exert their effect there (Probable).
CC {ECO:0000269|PubMed:29371424, ECO:0000305|PubMed:29371424}.
CC -!- SUBCELLULAR LOCATION: Cell inner membrane
CC {ECO:0000305|PubMed:29371424}; Multi-pass membrane protein
CC {ECO:0000255}.
CC -!- DISRUPTION PHENOTYPE: When this gene is missing the Zorya system does
CC not confer resistance to SECphi27 in E.coli.
CC {ECO:0000269|PubMed:29371424}.
CC -!- SIMILARITY: Belongs to the MotA family. {ECO:0000305|PubMed:29371424}.
CC -!- SEQUENCE CAUTION:
CC Sequence=ABV17222.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305|PubMed:29371424};
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CP000800; ABV17222.1; ALT_INIT; Genomic_DNA.
DR EnsemblBacteria; ABV17222; ABV17222; EcE24377A_0285.
DR KEGG; ecw:EcE24377A_0285; -.
DR HOGENOM; CLU_022865_0_0_6; -.
DR OMA; FGGQMRG; -.
DR Proteomes; UP000001122; Chromosome.
DR GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
PE 1: Evidence at protein level;
KW Antiviral defense; Cell inner membrane; Cell membrane; Membrane;
KW Transmembrane; Transmembrane helix.
FT CHAIN 1..729
FT /note="Zorya protein ZorA"
FT /id="PRO_0000456338"
FT TRANSMEM 20..40
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 135..155
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 177..197
FT /note="Helical"
FT /evidence="ECO:0000255"
FT MUTAGEN 147
FT /note="T->A: No longer resistant to SECphi27; when
FT associated with A-184."
FT /evidence="ECO:0000269|PubMed:29371424"
FT MUTAGEN 184
FT /note="S->A: No longer resistant to SECphi27; when
FT associated with A-147."
FT /evidence="ECO:0000269|PubMed:29371424"
SQ SEQUENCE 729 AA; 80261 MW; E17594C6170F03A5 CRC64;
MSWLNSVLLA LTSVQPYMVP ATVIGLVSFA FLCFIFFYFF RAVKIINGLK KYTQSINGIE
NNEPGNQLQH LQSLFVQPEL KHAWNEFEES LHSQYELEDG EEKIVRIRAT APSASFFSEQ
QLVDIPLNTE FFKHLPGILT GVGIIGTFYG LMIGLNHFDP STPEQVSSSV NNLLRDVLYA
FLGSAFAITF SILITWLEKF CLAKCYKYLE KFTAALDALY DSGVGEEYLA SLVKSSNESA
TQARHLKESL VTDLRDMLLH LANSQKVENE RLATTLSTTY RETGQQFAEQ VSGAIENSLK
SPLDKIAGAV QTASGDQSGM VQNMLQDVLT AFMAKLDTTF GQQFTNLNEM MGQTVGAIQT
MQTGFGALLQ DMRQVSDDSR QGSAQLIEQL LSEMKSGQQA MQAGMNDMLT SLQTSVAKIG
AEGEGAGERM ARQLEKMFAD SEAREKAQAE HMTAFIEAIQ NSVQQGQSAT MEKMAASVES
LGEQLGSLFG QIDKGQQQIS ANQQANQQSL HEQTQRVMSE VDDQIKQLVE TVASQHQGTT
ETLRLLAEQT NRQIQDMHTG ADKMRLAAER FEHAGDRVSE ANHLTADVLN KAQSAGSSLS
LATSELTSVV ADYRNNREAV SKSIAMLELL AANTQSEQTT RTQFIADLKQ HGERLQSYNR
EAQAFMENVS DVLGKGFEDF SEGVSRSLDK TLGKLDVEMA KASTLLAGSV EQIGESVSEL
DDVLSRVRA